Models of In-Vivo Bacterial Infections for the Development of Antimicrobial Peptide-based Drugs

Author(s): Jlenia Brunetti, Chiara Falciani, Luisa Bracci, Alessandro Pini

Journal Name: Current Topics in Medicinal Chemistry

Volume 17 , Issue 5 , 2017

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


The increasing frequency of multi-resistant Gram-positive and Gram-negative bacteria and a long-term decreasing trend in the development of new antimicrobial molecules prompts research for new anti-infective agents with new modes of action.

Antimicrobial peptides (AMPs) are considered an interesting class of antibacterial molecules. Many new AMPs have been discovered and some are being evaluated for the development of new antibacterial therapeutics. Since the development of new antibacterial drugs has been neglected for decades, we are now faced with extreme medical need combined with a lack of technical experimental progress in setting up efficient models of antibacterial activity in animals. Here we review experiments with AMPs in animal models of sepsis, pneumonia and skin infection caused by bacteria. Animal models of infection have been of enormous predictive value in antibacterial drug discovery, both for elucidating AMP efficacy in the treatment of experimentally induced infection and for comparing the effectiveness of two or more antibiotics.

Keywords: Antimicrobial peptides, In vivo models, Infection, Superbugs.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 13 July, 2016
Page: [613 - 619]
Pages: 7
DOI: 10.2174/1568026616666160713143017
Price: $65

Article Metrics

PDF: 73